Drug
Escitalopram clinical trials
Also written Lexapro and Cipralex.
- studies test it
- 280
- open now
- 19
- in phase 3
- 55
- first study started
- 2001
Keep track of what changes. Save the Escitalopram studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Escitalopram
- 218
Studies by the year they started
273 studies that test it; most in 2008 (32)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 10 |
| 2003 | 9 |
| 2004 | 15 |
| 2005 | 24 |
| 2006 | 23 |
| 2007 | 18 |
| 2008 | 32 |
| 2009 | 24 |
| 2010 | 23 |
| 2011 | 8 |
| 2012 | 10 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 10 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 10 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 25
- Phase 2
- 32
- Phase 3
- 55
- Phase 4
- 127
- No phase
- 52
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 38 · Other 242
New York State Psychiatric Institute (11) · Massachusetts General Hospital (10) · Duke University (7) · University of Pennsylvania (6) · Weill Medical College of Cornell University (6) · Emory University (6) · Seoul National University Hospital (6) · Forest Laboratories (6)
Often tested with
Tested in the same studies.
Bupropion (14) · Duloxetine (11) · Sertraline (10) · Aripiprazole (8) · Venlafaxine (8) · Citalopram (5) · Quetiapine (5) · Paroxetine (3)
Studies
Open first, then newest update. How each study uses Escitalopram is read from its arms, and is right about nine times in ten.
Testing it · 280
- Home Transcutaneous Electrical Acustimulation (TEA)RecruitingPhase 2/3University of MichiganNCT05519683Written as Lexapro
- Escitalopram and Language Intervention for Subacute AphasiaRecruitingPhase 2Johns Hopkins UniversityNCT03843463Written as Escitalopram 10mg
- Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive DisorderRecruitingNot applicablePeking UniversityNCT07480525Written as Escitalopram (Oral antidepressant)
- Aβ Dynamics in LLMDRecruitingPhase 4NYU Langone HealthNCT05004987Written as Escitalopram Oxalate
- A Study Utilizing Escitalopram in Glioma PatientsRecruitingPhase 2University of NebraskaNCT03728673Written as Escitalopram Oral Capsules
- TDM-Guided Treatment With SSRIs in Hospitalized Adults and ChildrenRecruitingPhase 4Poznan University of Medical SciencesNCT07478796Written as Escitalopram
- Neuroimaging of Escitalopram in Autism Spectrum DisorderEnrolling by invitationPhase 2Kathryn UnruhNCT06826326Written as Escitalopram 10mg
- Escitalopram in Asthma Patients With Frequent ExacerbationRecruitingPhase 2University of Texas Southwestern Medical CenterNCT06216535Written as Escitalopram
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureRecruitingPhase 3Dr. Inge WinterNCT05603104Written as Esketamine Nasal Product
- The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingPhase 3Dr. Inge WinterNCT05973786Written as Escitalopram
- The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingPhase 3Dr. Inge WinterNCT05973851Written as Esketamine Nasal Product
- Effort and Antidepressant Study TestNot yet recruitingPhase 1/2University of OxfordNCT06696482Written as Escitalopram 10mg
- Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed PeopleRecruitingPhase 4Medical University of ViennaNCT06675851Written as Cipralex (escitalopram)
- Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)RecruitingPhase 4University of CincinnatiNCT04245748Written as Escitalopram
- Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)RecruitingPhase 4University of CincinnatiNCT04623099Written as Escitalopram
- Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)RecruitingPhase 4University of CincinnatiNCT04245436Written as Escitalopram
- Psychopharmacotherapy for Depressive PatientsRecruitingNot applicableChonnam National University HospitalNCT06054321Written as stepwise pharmacotherapy
- Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on AnhedoniaRecruitingNot applicablePeking UniversityNCT05389046Written as Escitalopram
- Chinese Longitudinal and Systematic Study of Bioplar DisorderRecruitingNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT05480150Written as Escitalopram Oxalate Tablets
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVSuspendedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06705478Written as Escitalopram
See all 280 studies that test Escitalopram →
Given in every arm · 34 — Escitalopram is usual care beside what is tested
- Efficacy and Safety of Probiotics for Anxiety DepressionRecruitingNot applicableMoon (Guangzhou) Biotechnology Co., Ltd.NCT07331987Written as Escitalopram
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)RecruitingPhase 4Nova Scotia Health AuthorityNCT05017311Written as Escitalopram
- Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive DisorderRecruitingNot applicableGang WangNCT06692361Written as Escitalopram (Lexapro)
- MBCT and Escitalopram for Treatment-Resistant Depression in Older AdultsCompletedNot applicableYun ZhangNCT07077291Written as Escitalopram Hydrobromide
- The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder PatientsWithdrawnPhase 1/2Sadat City UniversityNCT04410341Written as Escitalopram 20 mg
- Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.CompletedEarly Phase 1Zhejiang UniversityNCT03887624Written as Escitalopram
- A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02493868Written as Escitalopram (Oral antidepressant)
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02422186Written as Escitalopram (Oral Antidepressant)
- A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT03434041Written as Escitalopram (Oral Antidepressant)
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02417064Written as Escitalopram (Oral antidepressant)
- A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02497287Written as Escitalopram (Oral Antidepressant)
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02418585Written as Escitalopram (Oral antidepressant)
- A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant DepressionWithdrawnPhase 3Janssen-Cilag International NVNCT03852160Written as Escitalopram
- RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDDCompletedNot applicablePeking University Sixth HospitalNCT06758167Written as Escitalopram
- Adjunctive Game Intervention for Anhedonia in MDD PatientsCompletedNot applicableCentral South UniversityNCT04977232Written as Escitalopram
- Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar DepressionCompletedPhase 4Loyola UniversityNCT01479829Written as Escitalopram
- A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderCompletedPhase 3BiogenNCT04476030Written as Escitalopram
- The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.CompletedNot applicableSadat City UniversityNCT04069819Written as Escitalopram
- Brain Aging and Treatment Response in Geriatric DepressionCompletedPhase 4University of California, Los AngelesNCT01902004Written as Escitalopram
- Time to Remission of Depressive Symptoms With Combined SSRI and RamelteonTerminatedPhase 3University of Texas Southwestern Medical CenterNCT00642694Written as Escitalopram
Showing 20 of 34.
As the comparator · 42 — what is tested is compared with Escitalopram
- Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDDRecruitingPhase 2Vigonvita Life SciencesNCT06828887Written as Escitalopram
- Development and Application of Comprehensive Intervention Techniques for Adolescent DepressionRecruitingNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT05945342Written as Escitalopram
- Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth SyndromeRecruitingPhase 3Federico II UniversityNCT06025474Written as Escitalopram 10mg
- Efficacy of Hydroxyzine for Patients With Panic DisorderNot yet recruitingPhase 4Sultan Qaboos UniversityNCT05737511Written as Escitalopram Oxalate
- Mindfulness and Biofeedback for Anxiety DisordersCompletedPhase 4I.M. Sechenov First Moscow State Medical UniversityNCT07628153Written as Escitalopram 10 mg/day
- A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PETCompletedPhase 1Vigonvita Life SciencesNCT06476509Written as Escitalopram 20 mg
- Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsCompletedPhase 2Imperial College LondonNCT03429075Written as Psilocybin + Escitalopram
- Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).CompletedPhase 2/3The University of Hong KongNCT03909217Written as Escitalopram
- Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent DepressionCompletedNot applicableZhen-Hong HuNCT06325605Written as Escitalopram Oxalate
- Bupropion Versus Escitalopram on Reward Circuitry and Motivational DeficitsCompletedPhase 4Emory UniversityNCT04352101Written as Escitalopram
- Mirtazapine in Cancer-related Poly-symptomatologyTerminatedPhase 3Hospices Civils de LyonNCT04763135Written as Escitalopram
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentCompletedPhase 4Azienda Ospedaliera Universitaria Integrata VeronaNCT03779789Written as Escitalopram
- Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social AnxietyCompletedNot applicableTel Aviv UniversityNCT03346239Written as Escitalopram
- Treatments for Anxiety: Meditation and EscitalopramCompletedPhase 4Georgetown UniversityNCT03522844Written as Escitalopram
- Leveraging EEG for Antidepressant Prediction With Sertraline and EscitalopramWithdrawnPhase 4Alto NeuroscienceNCT04388202Written as Escitalopram
- Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive DisorderCompletedPhase 3GlaxoSmithKlineNCT02191397Written as Escitalopram
- Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive DisorderStatus unknownNot applicableShanghai Mental Health CenterNCT03899194Written as escitalopram
- A Study for Participants With Major DepressionCompletedPhase 2Eli Lilly and CompanyNCT00420004Written as Escitalopram
- Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic SymptomsTerminatedPhase 4Massachusetts General HospitalNCT00955474Written as escitalopram
- Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major DepressionCompletedNot applicableMaurizio Fava, MDNCT00101452Written as Escitalopram
Showing 20 of 42.
Codes
What other systems call Escitalopram · ClinicalTrials.gg INT006855
- MeSH (NLM) D000089983EscitalopramConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4O4S742ANYESCITALOPRAMConfirmed FDA, NLM, Wikidata
- RxNorm 321988Confirmed FDA, Wikidata
- Wikidata Q423757escitalopramConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61754EscitalopramOne source FDA
- DrugBank DB01175One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000089983 | Escitalopram | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4O4S742ANY | ESCITALOPRAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 321988 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423757 | escitalopram | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61754 | Escitalopram | One source FDA |
| DrugBank | DB01175 | — | One source Wikidata |
Also registered as escitalopram oxalate (UNII 5U85DBW7LO · RxNorm 353108).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.